Galderma Group AG - Voting results of the Annual General Meeting 2026

Number Item

Votes represented

Votes FOR

%

Votes AGAINST

%

Abstention

%

1 Approval of Financial Statements, Non-Financial Report and Compensation Report

1.1 Approval of statutory financial statements and consolidated financial statements

161,005,605

160,452,320

99.66

76,543

0.05

476,742

0.29

1.2 Approval of report on non-financial matters

161,005,899

150,511,148

93.48

10,088,521

6.27

406,230

0.25

1.3 Consultative vote on the compensation report

161,005,899

98,329,517

61.07

61,773,607

38.37

902,775

0.56

2 Appropriation of Available Earnings and Dividend Payment

161,005,822

160,708,170

99.82

277,815

0.17

19,837

0.01

3 Discharge of the Members of the Board of Directors and the Executive Committee from Liability

159,039,399

156,300,411

98.28

1,851,657

1.16

887,331

0.56

4 Election of the Members of the Board of Directors and the Compensation Committee

4.1.1 Re-election of Thomas Ebeling as Member and Chair of the Board

161,005,899

153,574,732

95.39

5,958,836

3.70

1,472,331

0.91

4.1.2 Re-election of Daniel Browne as Member of the Board

161,005,899

160,841,620

99.90

151,841

0.09

12,438

0.01

4.1.3 Re-election of Maria Teresa Hilado as Member of the Board

161,005,899

157,104,041

97.58

3,890,442

2.41

11,416

0.01

4.1.4 Re-election of Karen Lee Ling as Member of the Board

161,005,899

145,831,186

90.58

15,158,577

9.41

16,136

0.01

4.1.5 Re-election of Roberto de Oliveira Marques as Member of the Board

161,005,899

157,722,232

97.96

3,270,925

2.03

12,742

0.01

4.1.6 Re-election of Sherilyn McCoy as Member of the Board

161,005,899

155,613,258

96.65

5,380,964

3.34

11,677

0.01

4.1.7 Re-election of Dr. Flemming Ørnskov as Member of the Board

161,005,758

142,704,585

88.63

17,334,427

10.77

966,746

0.60

4.2.1.1 Election of Harry Kirsch as Member of the Board

161,005,956

160,844,158

99.90

138,390

0.09

23,408

0.01

4.2.2.1 Election of Samuel du Retail as Member of the Board

161,005,215

128,096,545

79.56

31,948,027

19.84

960,643

0.60

4.2.2.2 Election of Delphine Viguier-Hovasse as Member of the Board

161,005,215

128,069,415

79.54

31,977,378

19.86

958,422

0.60

4.3.1 Re-election of Karen Lee Ling as Member of the Compensation Committee

161,005,891

139,294,366

86.52

21,689,443

13.47

22,082

0.01

4.3.2 Re-election of Thomas Ebeling as Member of the Compensation Committee

161,005,891

149,013,196

92.55

10,517,357

6.53

1,475,338

0.92

4.3.3 Re-election of Roberto de Oliveira Marques as Member of the Compensation Committee

161,005,891

153,063,190

95.07

7,927,345

4.92

15,356

0.01

5 Approval of the Maximum Aggregate Compensation of the Board of Directors and the Executive Committee

5.1 Approval of the maximum aggregate compensation of the Board of Directors

160,997,418

159,906,693

99.32

1,025,260

0.64

65,465

0.04

5.2 Approval of the maximum aggregate compensation of the Executive Committee

161,003,474

99,828,459

62.00

60,225,574

37.41

949,441

0.59

6 Re-election of the Independent Proxy

161,005,446

159,888,532

99.31

1,109,038

0.69

7,876

-

7 Re-election of the External Auditors

161,003,434

160,864,351

99.91

121,424

0.08

17,659

0.01

Attachments

  • Original document
  • Permalink

Disclaimer

Galderma Group AG published this content on May 06, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 06, 2026 at 14:59 UTC.